David Hochman serves as the Chairman and Chief Executive Officer of Orchestra BioMed, having directed the enterprise since May 2018. Bringing extensive venture capital and medical technology experience—including his previous role as Managing Partner of Orchestra Medical Ventures—he leads the company's strategic vision, clinical programs, and corporate partnerships. Under his executive leadership, the organization focuses on advancing high-impact biomedical and cardiovascular therapeutic solutions, securing strategic funding collaborations with major global healthcare enterprises, and driving its core clinical pipelines through complex regulatory pathways toward commercialization.